GEOapplication/xmlftp://ftp.ncbi.nlm.nih.gov/geo/series/GSE301nnn/GSE301248/primaryOK200TranscriptomicsHomo sapiensExpression profiling by high throughput sequencinghttps://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE301248GEOGSEfalseScalable Generation of Hematopoietic Stem Cells Engineered Off-the-Shelf Mono-Specific Cytotoxic T Cells Targeting Solid TumorsAdoptive T cell therapy has emerged as a promising strategy for treating solid tumors. However, its clinical application remains constrained by major limitations, including manufacturing complexity in autologous settings and risks of graft-versus-host disease (GvHD), HLA restriction and donor variability in allogeneic contexts. To address these challenges, we present a scalable platform for the generation of hematopoietic stem and progenitor cell (HSPC)-derived, mono-specific cytotoxic T cells targeting the NY-ESO-1 antigen. Using an ex vivo, feeder-free, serum-free culture system, we differentiate gene-engineered HSPCs into allogeneic T cells (AlloESO-T) with a uniform cytotoxic phenotype and robust antitumor activity. These cells employ dual tumor-targeting strategies by antigen-specific killing via a transgenic TCR, and antigen-independent cytotoxicity via natural killer receptors. Compared to conventional PBMC-derived TCR-T cells, Allogeneic ESO-T cells display superior cytotoxic potency, selective solid tumor homing, durable killing persistence, and resilience against immune evasion. Notably, they exhibit a favorable safety profile, with low risks of graft-versus-host disease (GvHD) and cytokine release syndrome (CRS), alongside stable hypoimmunogenic features. Collectively, our findings demonstrate the feasibility, universality, and therapeutic potential of HSPC-engineered, off-the-shelf mono-specific cytotoxic T cells. This work lays a foundation for next-generation T cell immunotherapies that are scalable, safe, and broadly applicable to diverse solid tumors.2026/07/15GSE301248GSM9078739GSM9078737GSM9078738GSM9078735GSM9078736GSM907874024676301248Homo sapiens